Liu, Chunyan
Fang, Fang
Kong, Ying
ElGabry, Ehab A.
Funding for this research was provided by:
Roche Tissue Diagnostics
Article History
Received: 26 October 2022
Accepted: 22 February 2023
First Online: 19 April 2023
Declarations
:
: Institutional review board approval was obtained by the Roche Tissue Diagnostics Clinical Operation Department. The two reader precision studies used commercial samples. For the samples used in the comparison study, which were collected as part of a BeiGene study, consent was obtained in compliance with requirements.
: Not applicable.
: CL and FF were employees of Roche Tissue Diagnostics at the time of the study. YK is an employee of Roche Tissue Diagnostics. EAE is Chief Medical Officer of Akoya Biosciences Inc. and was an employee of Roche Tissue Diagnostics at the time of the study.